---
figid: PMC6000947__13058_2018_981_Fig5_HTML
figtitle: Model of crosstalk between triple negative breast cancer (TNBC) and lymphatic
  endothelial cells (LECs)
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Ornithorhynchus anatinus
- Homo sapiens
- Mus musculus
- Gallus gallus
pmcid: PMC6000947
filename: 13058_2018_981_Fig5_HTML.jpg
figlink: /pmc/articles/PMC6000947/figure/Fig5/
number: F5
caption: Model of crosstalk between triple negative breast cancer (TNBC) and lymphatic
  endothelial cells (LECs). In TNBC, secreted IL-6 from TNBC cells binds to IL-6 receptor
  in LECs, which enhances CCL5 secretion by activating the STAT3 signaling pathway
  in LECs. The interaction of CCL5 and CCR5 consequently promotes TNBC tumor growth
  and metastasis. Therefore, maraviroc and tocilizumab are potential therapeutic drugs
  to inhibit TNBC tumor growth and metastasis
papertitle: Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition
  of triple-negative breast cancer growth and metastasis.
reftext: Kideok Jin, et al. Breast Cancer Res. 2018;20:54.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8302814
figid_alias: PMC6000947__F5
figtype: Figure
organisms_ner:
- Bos taurus
- Gallus gallus
- Oryctolagus cuniculus
- Capra hircus
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC6000947__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6000947__13058_2018_981_Fig5_HTML.html
  '@type': Dataset
  description: Model of crosstalk between triple negative breast cancer (TNBC) and
    lymphatic endothelial cells (LECs). In TNBC, secreted IL-6 from TNBC cells binds
    to IL-6 receptor in LECs, which enhances CCL5 secretion by activating the STAT3
    signaling pathway in LECs. The interaction of CCL5 and CCR5 consequently promotes
    TNBC tumor growth and metastasis. Therefore, maraviroc and tocilizumab are potential
    therapeutic drugs to inhibit TNBC tumor growth and metastasis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - IL6R
  - CCR5
  - CCL5
  - Sema6a
  - Il6
  - Il6ra
  - Ccr5
  - Ccl5
  - lec
  - Ccl16-ps
  - SEMA6A
  - CCL16
  - Maraviroc
  - TNBC tumor
---
